NCT03609190View on ClinicalTrials.gov

A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

Ketamine

i.v. infusion of 0.25 mg/kg S-ketamine over 40 min

DRUG

Placebo

i.v. infusion of NaCl over 40 min

All Listed Sponsors
lead

Psychiatric University Hospital, Zurich

OTHER

NCT03609190 - A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine | Biotech Hunter | Biotech Hunter